COVID-19 Cure Using Integrative Treatment

The Effectiveness of Integrative Treatment Interventions on Covid-19 Patients: A Clinical Trial Based Evaluation

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000040632

Enrollment

Unknown

Registered

2020-12-04

Start date

2020-03-17

Completion date

Unknown

Last updated

2021-03-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

Single:integrative treatment

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: a. Both genders; b. Aged between 18-80 years; c. Mild, moderate or severe infection; d. COVID-19 positive on the basis of symptoms, physical test and lab test.

Exclusion criteria

Exclusion criteria: a. Any tumor or malignancy b. Recent surgery c. Patient on invasive / non-invasive ventilator (critical) d. Taking any other medicine parallel to PAK-20 and Oniater for treatment of COVID-19. Taking any immunosuppressant

Design outcomes

Primary

Measure	Time frame
Fever;Cough;Sore Throat;Muscle Pain;COVID-19;10 Second Breath Hold Test;Chest X-ray;	—

Countries

Pakistan

Contacts

Public ContactMuhammad Yahya Qureshi

Knowledge Research and Innovation Center, Pakistan (KRIC)

yahya@kric.edu.pk+92 33 49646099

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026